Diwakar Davar
Clinical trials sponsored by Diwakar Davar, explained in plain language.
-
Poop pills may tame cancer Treatment's worst side effects
Disease control Recruiting nowThis study is testing whether pills containing healthy donor gut bacteria can help control severe skin rashes and colon inflammation in cancer patients. These side effects are caused by powerful immunotherapy drugs and often don't respond well to standard steroid treatments. The …
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for rare eye cancer: experimental drug targets deadly metastases
Disease control Recruiting nowThis study is testing an experimental drug called tebentafusp in people with metastatic uveal melanoma, a rare but aggressive eye cancer that has spread to other parts of the body. The trial will enroll 44 previously untreated patients who have a specific genetic marker (HLA-A*02…
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Gut bacteria transplant trial aims to reboot Cancer-Fighting power
Disease control Recruiting nowThis study is testing if a healthy donor stool transplant (FMT) can help the body fight cancer when given alongside the immunotherapy drug pembrolizumab. It is for people with advanced non-small cell lung cancer where prior immunotherapy has stopped working. The goal is to see if…
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Cancer patients choose: quick shot or IV drip?
Symptom relief Recruiting nowThis study asks cancer patients which way they prefer to receive their immunotherapy drugs: as a quick injection under the skin or through a longer IV infusion. Researchers will enroll 480 people with various advanced cancers to compare comfort, convenience, and quality of life b…
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC